You have 9 free searches left this month | for more free features.

antihistamine

Showing 1 - 19 of 19

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

SARS-CoV-2 Infection

Recruiting
  • COVID-19
  • Terrassa, Barcelona, Spain
  • +1 more
Aug 15, 2022

Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

Active, not recruiting
  • Breast Neoplasms
  • Chuo Ku, Japan
  • +1 more
Dec 19, 2022

Peanut Allergy Trial in Hamilton (Peanut protein, Oat flour, Antihistamine)

Completed
  • Peanut Allergy
  • Peanut protein
  • +2 more
  • Hamilton, Ontario, Canada
    McMaster University
Jan 18, 2022

Multiple Sclerosis, Infusion Reaction Trial in Portland (antihistamine)

Active, not recruiting
  • Multiple Sclerosis
  • Infusion Reaction
  • antihistamine
  • Portland, Oregon
    Providence Neurological Specialties West
Jan 10, 2022

Antihistamine Responsive Irritable Bowel Syndrome With Diarrhea

Unknown status
  • Irritable Bowel Syndrome
  • +2 more
  • Antihistamine
  • (no location specified)
Oct 28, 2020

Asthma in Children Trial in Cincinnati (Cholecalciferol, antihistamine, Azithromycin)

Completed
  • Asthma in Children
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Jul 28, 2021

Circulating Tumor Cell, Metastatic Prostate Cancer Trial in Netherlands (Cabazitaxel, Antihistamine, Corticosteroid)

Active, not recruiting
  • Circulating Tumor Cell
  • Metastatic Prostate Cancer
  • Delft, Netherlands
  • +8 more
Aug 19, 2021

Relapsing Multiple Sclerorsis, Multiple Sclerosis, Primary Progressive Trial in Worldwide (Ocrelizumab, Lumbar Puncture,

Active, not recruiting
  • Relapsing Multiple Sclerorsis
  • Multiple Sclerosis, Primary Progressive
  • Palo Alto, California
  • +16 more
Jul 26, 2022

Hepatitis B Trial in China, Germany, Korea, Republic of (ARC-520 Injection, entecavir, tenofovir)

Terminated
  • Hepatitis B
  • ARC-520 Injection
  • +3 more
  • Hong Kong, China
  • +5 more
Jan 11, 2019

Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

Recruiting
  • Multiple Sclerosis
  • Cullman, Alabama
  • +202 more
Jan 27, 2023

Multiple Sclerosis Trial in Worldwide (Ocrelizumab, Antihistamine, Methylprednisolone)

Recruiting
  • Multiple Sclerosis
  • Homewood, Alabama
  • +211 more
Jan 13, 2023

Hepatitis B Trial in Grafton (ARC-521 Injection, Placebo, antihistamine)

Terminated
  • Hepatitis B
  • ARC-521 Injection
  • +5 more
  • Grafton, Auckland, New Zealand
    Auckland Clinical Studies Ltd
Jan 10, 2018

Hepatitis B Trial in China, Germany, Korea, Republic of (ARC-520 Injection, , entecavir)

Terminated
  • Hepatitis B
  • ARC-520 Injection
  • +4 more
  • Hong Kong, China
  • +15 more
Jan 11, 2019

Hepatitis B Trial in China, Germany, Korea, Republic of (ARC-520, Placebo, entecavir)

Terminated
  • Hepatitis B
  • Hong Kong, China
  • +15 more
Jan 11, 2019

Hepatitis B, Hepatitis D Trial in Worldwide (ARC-520, entecavir, pegylated interferon alpha 2a)

Terminated
  • Hepatitis B
  • Hepatitis D
  • Camperdown, New South Wales, Australia
  • +32 more
Jan 11, 2019

Rheumatoid Arthritis Trial in United States (rituximab, methotrexate, methylprednisolone)

Completed
  • Rheumatoid Arthritis
  • Birmingham, Alabama
  • +85 more
Jul 5, 2017

Graft Rejection Trial in Cincinnati (Rabbit Antithymocyte Globulin (RATG), Rituximab, Bortezomib)

Completed
  • Graft Rejection
  • Rabbit Antithymocyte Globulin (RATG)
  • +5 more
  • Cincinnati, Ohio
  • +1 more
Dec 17, 2015

Eustachian Tube Dysfunction, Endolymphatic Hydrops Trial in Nashville (drug, procedure, behavioral)

Withdrawn
  • Eustachian Tube Dysfunction
  • Endolymphatic Hydrops
  • Nasal steroid
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University Medical Center--Division of Neurotology
May 28, 2014

Otitis Media Trial in Galveston (Antihistamine, Corticosteroid)

Completed
  • Otitis Media
  • Galveston, Texas
    Univ of Texas Med Branch Children's Hosp
Apr 21, 2006